Tumor-stroma co-evolution in prostate cancer progression and metastasis. - Wikidata - thesis-toulmin - TriplyDB

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

http://www.wikidata.org/entity/Q37641468

about

Osteoprotegerin rich tumor microenvironment: implications in breast cancer Mast cells as a potential prognostic marker in prostate cancer Expression differences between African American and Caucasian prostate cancer tissue reveals that stroma is the site of aggressive changes A versatile, bar-coded nuclear marker/reporter for live cell fluorescent and multiplexed high content imaging Oxidative stress, inflammation, and cancer: how are they linked?RANK-mediated signaling network and cancer metastasis.Convergent RANK- and c-Met-mediated signaling components predict survival of patients with prostate cancer: an interracial comparative study.Radium-223 chloride: a potential new treatment for castration-resistant prostate cancer patients with metastatic bone disease.Prostate cancer and bone: the elective affinities.Curcumin Inhibits Prostate Cancer Bone Metastasis by Up-Regulating Bone Morphogenic Protein-7 in Vivo Polarization of prostate cancer-associated macrophages is induced by milk fat globule-EGF factor 8 (MFG-E8)-mediated efferocytosis.Characterization of subepithelial interstitial cells in normal and pathological human prostate.Frequent gene products and molecular pathways altered in prostate cancer- and metastasis-initiating cells and their progenies and novel promising multitargeted therapies.Bone-modifying agents in the treatment of bone metastases in patients with advanced genitourinary malignancies: a focus on zoledronic acid.Multiwalled carbon nanotubes interact with macrophages and influence tumor progression and metastasis.Co-Targeting Prostate Cancer Epithelium and Bone Stroma by Human Osteonectin-Promoter-Mediated Suicide Gene Therapy Effectively Inhibits Androgen-Independent Prostate Cancer Growth Future perspectives of prostate cancer therapy.Osteoblast-secreted collagen upregulates paracrine Sonic hedgehog signaling by prostate cancer cells and enhances osteoblast differentiation.Biomarkers in the management and treatment of men with metastatic castration-resistant prostate cancer.Microenvironmental interactions and expression of molecular markers associated with epithelial-to-mesenchymal transition in colorectal carcinoma.The VEGF pathway in cancer and disease: responses, resistance, and the path forward.Metastasis initiating cells in primary prostate cancer tissues from transurethral resection of the prostate (TURP) predicts castration-resistant progression and survival of prostate cancer patients Matrilysin/matrix metalloproteinase-7(MMP7) cleavage of perlecan/HSPG2 creates a molecular switch to alter prostate cancer cell behavior.New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.The stroma-a key regulator in prostate function and malignancy Molecular pathogenesis and progression of prostate cancer Oxidative stress in angiogenesis and vascular disease Silibinin inhibits prostate cancer cells- and RANKL-induced osteoclastogenesis by targeting NFATc1, NF-κB, and AP-1 activation in RAW264.7 cells.Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts.Steps in prostate cancer progression that lead to bone metastasis Targeting the tumor microenvironment by immunotherapy: part 2.Molecular targets for radiation oncology in prostate cancer.Advances for studying clonal evolution in cancer.Tumor indicating normal tissue could be a new source of diagnostic and prognostic markers for prostate cancer.Cell mates: paracrine and stromal targets for prostate cancer therapy.Leading causes of castration-resistant prostate cancer.Prognostic, predictive and potential surrogate markers in castration-resistant prostate cancer.Identification of Bone-Derived Factors Conferring De Novo Therapeutic Resistance in Metastatic Prostate Cancer.Regulation of prostate stromal fibroblasts by the PIM1 protein kinase.Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b.

P2860

Q26748804-B667F7CC-C8F1-4DD0-8926-0D25F4576A30 Q26827773-D6277D23-0198-4E97-ACA3-4D14D9B8C927 Q28292423-C7980C27-3625-433D-984B-5FF593E3DE6F Q28488026-8D3CA705-F649-46B4-84FA-4BAD5E7D952E Q29616835-5623DDEC-8097-4699-B179-2B09C46C2030 Q30371052-F6DA76D2-AE23-4CE5-A495-A3FE02975A88 Q30417094-E7B8A771-F603-4F83-B937-4B51A5ABE89F Q33405335-5605F6CF-D3D7-42C2-B198-7B3BC46B52F3 Q33757791-A6366325-2E4C-440F-A158-31AE4DB400FE Q33767832-A933AF0F-34F1-4542-99A6-759255203775 Q34107357-3DFCA4C3-49ED-4C0F-9E8A-76CA3753AF9C Q34406931-A74419C4-6CB0-4438-91B7-F72B0FA3999A Q35287094-29FD6BBB-B42E-4D7E-893F-079680903256 Q35865726-28FA9079-B4E2-4FA9-A3A6-83D2C98B098C Q35890028-36EC49D9-96F1-4C54-B928-5217FD96AAEE Q35982218-3107E4FB-FAA2-4A59-B2B8-955E95F7AD99 Q36076453-CF7D8BE2-0F0B-4060-BB25-B8FE04F16D49 Q36100749-649D6A7F-A120-4F95-A6D4-BFCD5CEF522A Q36243296-1E26309E-D886-42C6-BD4D-D27B458FDFBC Q36464398-EF5FB4E3-1501-4116-BD1E-F8301F4FB94C Q36526512-C025D508-56D1-4079-B8B7-F21851CE2D6C Q36530753-A4C018B8-C72C-4876-B9D6-D1D7A4C726D7 Q36566641-7FF7DF14-7963-40B2-BD32-58FF8949C121 Q36603335-5B36008E-1091-42D8-BE61-122D0DAD65AD Q37017028-BDE34DE9-88BC-472E-814B-82D9B917F7A0 Q37055715-AA13B354-CE1F-4F6F-AF1D-C6EB05D3B7FC Q37535220-C5774587-D6D9-45C9-8C74-E47D1FE0F96B Q37586474-A5B29FD0-A6E7-4A75-9D42-E84126D2941B Q37702066-846D9290-EF2D-45EB-AD0E-159E82D2E28E Q37848782-112CE8DE-3DA0-48E9-9571-3F9BD58DA035 Q37952796-E0ECD950-2E93-4482-BE40-5E6F3DAECB82 Q38014447-3654E922-A8FC-4BEE-BA95-6FA953F6723D Q38077016-F2C4160E-CB45-41C6-B466-23883F05E410 Q38088721-A379FE0A-C114-40F7-A3FD-D8FC3EC5A8D8 Q38121792-A71276EC-CBA8-423F-88FA-85970B06F662 Q38341864-5B0BBD71-9268-4784-865C-0AA21F74640F Q38438248-CD605CD1-0D92-4E87-98C2-075756DAE080 Q38822335-C66AD12A-D273-430A-A0D3-1450149A5DEE Q38934636-86B7113C-19A9-453B-A89A-745207EFF467 Q39372549-4C5424BF-8BB1-433C-B5FA-3BB94C205BB9

P2860

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

http://www.wikidata.org/entity/Q37641468

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 December 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@en

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@nl

type

label

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@en

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@nl

prefLabel

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@en

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@nl

P1433

Q37641468-AE792F91-CA9E-4686-B57C-ECA6FCFF5878

P1476

Q37641468-CD99D525-9DFC-464C-9EFE-F89A63ED6E75

P2093

Q37641468-0C6E5585-A33D-459C-81A8-9443939D404C

Q37641468-7FBABBA7-CA99-4826-8A0D-A9C546EA3C70

Q37641468-C83046B1-BEC1-4744-B648-51D1088D1B8D

Q37641468-D0933339-00BA-418D-83C0-30491D3AAF21

Q37641468-FAAD2E27-6C0A-4F55-8BB0-C79ABB04B39B

P2860

Q37641468-066E4A18-63DE-4CB1-AC7C-F6B783E1C192

Q37641468-12916FCD-4F57-4AF9-890A-E0DF6E5B3AB4

Q37641468-2306D14E-0465-4179-A415-F90FB73A85AC

Q37641468-23ADB03C-2F43-40C3-9177-D4D978556967

Q37641468-3414E3CD-944A-4B4C-AD6D-117E5BF169BB

Q37641468-3860E7CA-F820-4615-A55A-0EB55C1A0AB4

Q37641468-391286B0-8AF6-4D5B-8189-E90423F6115F

Q37641468-41916DBF-F685-4E19-9054-BE028DEA7374

Q37641468-465CC558-E156-4423-ADAD-445597CCEA4C

Q37641468-51A62EA1-14A6-4D3A-94F2-8880C4805207

P304

Q37641468-4322B9C6-6814-4300-B134-2D165650694B

P31

Q37641468-6AAB8983-22CC-4019-B7BD-F96F1B3415A5

P356

Q37641468-4B6FF4F7-67FA-4FA8-A563-08A240DBF79D

P433

Q37641468-9D91B4DA-1F4D-4E2D-92A8-0C8054BE15C6

P478

Q37641468-DDCF9204-6A7A-4144-9499-2D407F655C46

P577

Q37641468-998B7644-B1C7-4879-BCC5-5BA788697F83

P5875

Q37641468-C85B45ED-5776-492A-800E-6C7D98AB0461

P698

Q37641468-AC4E4361-4C75-453D-B5EC-DFDCAB5DD090

P921

Q37641468-CEB4E9C1-9F64-42EF-B210-5A2C7EC8E1BD

P932

Q37641468-6008EE7F-7B34-4EE6-985B-94583640254D

P356

J.SEMCDB.2009.11.016

P1433

Seminars in Cell & Developmental Biology

P1476

Tumor-stroma co-evolution in prostate cancer progression and metastasis.

@en

P2093

Haiyen E Zhau

http://www.w3.org/2001/XMLSchema#string

Leland W K Chung

http://www.w3.org/2001/XMLSchema#string

Ruoxiang Wang

http://www.w3.org/2001/XMLSchema#string

Sajni Josson

http://www.w3.org/2001/XMLSchema#string

Yasuhiro Matsuoka

http://www.w3.org/2001/XMLSchema#string

P2860

beta2-microglobulin is a signaling and growth-promoting factor for human prostate cancer bone metastasis

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Bone matrix proteins in osteogenesis and remodelling in the neonatal rat mandible as studied by immunolocalization of osteopontin, bone sialoprotein, alpha 2HS-glycoprotein and alkaline phosphatase

Expression of RANKL/RANK/OPG in primary and metastatic human prostate cancer as markers of disease stage and functional regulation

Immunoelectron microscopy of osteonectin and type I collagen in osteoblasts and bone matrix

Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment.

Permanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.

Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells

Coevolution of prostate cancer and bone stroma in three-dimensional coculture: implications for cancer growth and metastasis.

P304

26-32

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.SEMCDB.2009.11.016

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2009-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40041373

http://www.w3.org/2001/XMLSchema#string

P698

19948237

http://www.w3.org/2001/XMLSchema#string

P921

P932

3388105

http://www.w3.org/2001/XMLSchema#string